AI-powered oncology intelligence for predictive pathways and therapeutic discovery.
AI-powered oncology intelligence for predictive pathways and therapeutic discovery.
Jun 2026
MindNetQ acquires customers through targeted business development, strategic pharmaceutical partnerships, biotechnology collaborations, accelerator and incubator programs, scientific publications, conference presentations, and investor networks. Initial commercialization focuses on licensing, sponsored research collaborations, and platform partnerships with biotechnology and pharmaceutical organizations. As independent biological validation is completed, the company will expand through industry referrals, strategic alliances, and commercial partnerships.
Join thousands of founders, investors, and talents showcasing their startup journey.
Join Top Founders, Investors & Talent building the future
Trusted by founders from 20+ countries